PROPANC BIOPHARMA, INC. Debt Instrument, Increase, Accrued Interest
PROPANC BIOPHARMA, INC. (PPCB) reported Debt Instrument, Increase, Accrued Interest of $1.35 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Notes › Debt Instruments › Debt Instrument, Increase (Decrease), Net
us-gaap:DebtInstrumentIncreaseAccruedInterest · last filed 2016-11-10
- PROPANC BIOPHARMA, INC. debt instrument, increase, accrued interest for the quarter ending 2016-09-30 was $1.35K, a 77.60% decline year-over-year.
- PROPANC BIOPHARMA, INC. debt instrument, increase, accrued interest for the quarter ending 2015-09-30 was $6.03K, a 856.51% increase year-over-year.
- PROPANC BIOPHARMA, INC. debt instrument, increase, accrued interest for the quarter ending 2014-12-31 was $630.00.
- PROPANC BIOPHARMA, INC. debt instrument, increase, accrued interest for the quarter ending 2014-09-30 was $630.00.
- PROPANC BIOPHARMA, INC. debt instrument, increase, accrued interest for fiscal 2012 was $2.97K.
| Period end | Debt Instrument, Increase, Accrued Interest 0 month | Debt Instrument, Increase, Accrued Interest 3 month | Debt Instrument, Increase, Accrued Interest 6 month | Debt Instrument, Increase, Accrued Interest 9 month | Debt Instrument, Increase, Accrued Interest 12 month | Debt Instrument, Increase, Accrued Interest 51 month | Debt Instrument, Increase, Accrued Interest 54 month | Debt Instrument, Increase, Accrued Interest 57 month | Debt Instrument, Increase, Accrued Interest 60 month | Debt Instrument, Increase, Accrued Interest 63 month | Debt Instrument, Increase, Accrued Interest 66 month | Debt Instrument, Increase, Accrued Interest 75 month | Debt Instrument, Increase, Accrued Interest 77 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $1.35K 10-Q · filed 2016-11-10 | ||||||||||||
| 2015-09-30 | $6.03K 10-Q · filed 2015-11-16 | ||||||||||||
| 2014-12-31 | $630.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | $1.26K 10-Q · filed 2015-02-17 | |||||||||||
| 2014-09-30 | $630.00 10-Q · filed 2014-11-19 | ||||||||||||
| 2014-07-02 | $15.12K 10-Q · filed 2015-02-17 | ||||||||||||
| 2014-03-31 | $5.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-20 | $9.39K 10-Q · filed 2014-05-20 | $199.51K 10-Q · filed 2014-05-20 | ||||||||||
| 2013-12-31 | $4.26K 10-Q · filed 2014-02-14 | $194.38K 10-Q · filed 2014-02-14 | |||||||||||
| 2013-03-31 | -$700.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-20 | -$595.00 derived: sum of 2 quarters · filed 2014-05-20 | $851.00 10-Q · filed 2014-05-20 | $1.96K derived: sum of 4 quarters · filed 2014-05-20 | $187.63K 10-Q · filed 2013-05-20 | ||||||||
| 2012-12-31 | $105.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | $1.55K 10-Q · filed 2014-02-14 | $2.66K derived: sum of 3 quarters · filed 2014-02-14 | $3.72K derived: sum of 4 quarters · filed 2014-02-14 | $188.34K 10-Q · filed 2013-02-20 | ||||||||
| 2012-09-30 | $1.45K 10-Q · filed 2013-11-14 | $2.56K derived: sum of 2 quarters · filed 2013-11-14 | $3.62K derived: sum of 3 quarters · filed 2013-11-14 | $4.24K derived: sum of 4 quarters · filed 2013-11-14 | $188.23K 10-Q · filed 2012-11-19 | ||||||||
| 2012-06-30 | $1.11K derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-15 | $2.17K derived: sum of 2 quarters · filed 2013-05-20 | $2.79K derived: sum of 3 quarters · filed 2013-05-20 | $2.97K 10-K · filed 2012-10-15 | $186.78K 10-K · filed 2012-10-15 | ||||||||
| 2012-03-31 | $1.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-20 | $1.68K derived: sum of 2 quarters · filed 2013-05-20 | $1.86K 10-Q · filed 2013-05-20 | $185.68K 10-Q · filed 2012-05-21 | |||||||||
| 2011-12-31 | $623.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-20 | $797.00 10-Q · filed 2013-02-20 | $184.61K 10-Q/A · filed 2012-03-07 | ||||||||||
| 2011-09-30 | $174.00 10-Q · filed 2012-11-19 | ||||||||||||
| 2010-12-31 | $0.00 10-Q/A · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |